APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ephedrine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ephedrine Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchEphedrine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Ephedrine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Ephedrine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ephedrine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Ephedrine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ephedrine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ephedrine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ephedrine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ephedrine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ephedrine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ephedrine market include Malladi Drugs＆Pharmaceuticals, Medarex, Servier, Amgen, GlaxoSmithKline, Pfizer, Roche, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ephedrine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ephedrine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ephedrine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ephedrine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ephedrine Segment by Company

Malladi Drugs＆Pharmaceuticals

Medarex

Servier

Amgen

GlaxoSmithKline

Pfizer

Roche

Merck

Novartis

Sanofi

Ephedrine Segment by Type

Injection

Tablet

Capsule

Ephedrine Segment by Application

Recreational use

Medical use

Other uses

Ephedrine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ephedrine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ephedrine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ephedrine significant trends, drivers, influence factors in global and regions.

6. To analyze Ephedrine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ephedrine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ephedrine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ephedrine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ephedrine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ephedrine industry.

Chapter 3: Detailed analysis of Ephedrine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ephedrine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ephedrine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ephedrine Industry Trends Table 2. Ephedrine Industry Drivers Table 3. Ephedrine Industry Opportunities and Challenges Table 4. Ephedrine Industry Restraints Table 5. Global Ephedrine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ephedrine Revenue Share by Company (2021-2026) Table 7. Global Ephedrine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ephedrine Sales Volume Share by Company (2021-2026) Table 9. Global Ephedrine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ephedrine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ephedrine Key Company Manufacturing Base & Headquarters Table 12. Global Ephedrine Company, Product Type & Application Table 13. Global Ephedrine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ephedrine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablet Table 19. Significant Companies of Capsule Table 20. Global Ephedrine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Ephedrine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Ephedrine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Ephedrine Sales Volume Share by Type (2021-2026) Table 24. Global Ephedrine Sales Volume Share by Type (2027-2032) Table 25. Global Ephedrine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ephedrine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ephedrine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ephedrine Sales Value Share by Type (2021-2026) Table 29. Global Ephedrine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Recreational use Table 31. Significant Companies of Medical use Table 32. Significant Companies of Other uses Table 33. Global Ephedrine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Ephedrine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Ephedrine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Ephedrine Sales Volume Share by Application (2021-2026) Table 37. Global Ephedrine Sales Volume Share by Application (2027-2032) Table 38. Global Ephedrine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ephedrine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ephedrine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ephedrine Sales Value Share by Application (2021-2026) Table 42. Global Ephedrine Sales Value Share by Application (2027-2032) Table 43. Global Ephedrine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Ephedrine Sales by Region (2021-2026) & (K Units) Table 45. Global Ephedrine Sales Market Share by Region (2021-2026) Table 46. Global Ephedrine Sales by Region (2027-2032) & (K Units) Table 47. Global Ephedrine Sales Market Share by Region (2027-2032) Table 48. Global Ephedrine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ephedrine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ephedrine Sales Value Share by Region (2021-2026) Table 51. Global Ephedrine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ephedrine Sales Value Share by Region (2027-2032) Table 53. Global Ephedrine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Ephedrine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Ephedrine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Ephedrine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ephedrine Sales by Country (2021-2026) & (K Units) Table 58. Global Ephedrine Sales Market Share by Country (2021-2026) Table 59. Global Ephedrine Sales by Country (2027-2032) & (K Units) Table 60. Global Ephedrine Sales Market Share by Country (2027-2032) Table 61. Global Ephedrine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ephedrine Sales Value Market Share by Country (2021-2026) Table 63. Global Ephedrine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ephedrine Sales Value Market Share by Country (2027-2032) Table 65. Malladi Drugs＆Pharmaceuticals Company Information Table 66. Malladi Drugs＆Pharmaceuticals Business Overview Table 67. Malladi Drugs＆Pharmaceuticals Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Malladi Drugs＆Pharmaceuticals Ephedrine Product Portfolio Table 69. Malladi Drugs＆Pharmaceuticals Recent Development Table 70. Medarex Company Information Table 71. Medarex Business Overview Table 72. Medarex Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Medarex Ephedrine Product Portfolio Table 74. Medarex Recent Development Table 75. Servier Company Information Table 76. Servier Business Overview Table 77. Servier Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Servier Ephedrine Product Portfolio Table 79. Servier Recent Development Table 80. Amgen Company Information Table 81. Amgen Business Overview Table 82. Amgen Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Amgen Ephedrine Product Portfolio Table 84. Amgen Recent Development Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. GlaxoSmithKline Ephedrine Product Portfolio Table 89. GlaxoSmithKline Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer Ephedrine Product Portfolio Table 94. Pfizer Recent Development Table 95. Roche Company Information Table 96. Roche Business Overview Table 97. Roche Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Roche Ephedrine Product Portfolio Table 99. Roche Recent Development Table 100. Merck Company Information Table 101. Merck Business Overview Table 102. Merck Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Merck Ephedrine Product Portfolio Table 104. Merck Recent Development Table 105. Novartis Company Information Table 106. Novartis Business Overview Table 107. Novartis Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Novartis Ephedrine Product Portfolio Table 109. Novartis Recent Development Table 110. Sanofi Company Information Table 111. Sanofi Business Overview Table 112. Sanofi Ephedrine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sanofi Ephedrine Product Portfolio Table 114. Sanofi Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Ephedrine Distributors List Table 118. Ephedrine Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Ephedrine Product Image Figure 2. Global Ephedrine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ephedrine Sales (2021-2032) & (K Units) Figure 5. Global Ephedrine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ephedrine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablet Image Figure 11. Capsule Image Figure 12. Global Ephedrine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Ephedrine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ephedrine Sales Volume Share by Type (2021-2032) Figure 15. Global Ephedrine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ephedrine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ephedrine Sales Value Share by Type (2021-2032) Figure 18. Recreational use Image Figure 19. Medical use Image Figure 20. Other uses Image Figure 21. Global Ephedrine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Ephedrine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ephedrine Sales Volume Share by Application (2021-2032) Figure 24. Global Ephedrine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ephedrine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ephedrine Sales Value Share by Application (2021-2032) Figure 27. Global Ephedrine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Ephedrine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ephedrine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ephedrine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ephedrine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ephedrine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ephedrine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ephedrine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ephedrine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ephedrine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ephedrine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ephedrine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ephedrine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ephedrine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ephedrine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Capsule
Applications
  • Recreational use
  • Medical use
  • Other uses
Companies covered
  • Malladi Drugs＆Pharmaceuticals
  • Medarex
  • Servier
  • Amgen
  • GlaxoSmithKline
  • Pfizer
  • Roche
  • Merck
  • Novartis
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ephedrine Sales Value (2021-2032)
  4. 1.2.2 Global Ephedrine Sales Volume (2021-2032)
  5. 1.2.3 Global Ephedrine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ephedrine Market Dynamics
  1. 2.1 Ephedrine Industry Trends
  2. 2.2 Ephedrine Industry Drivers
  3. 2.3 Ephedrine Industry Opportunities and Challenges
  4. 2.4 Ephedrine Industry Restraints
3 Ephedrine Market by Company
  1. 3.1 Global Ephedrine Company Revenue Ranking in 2025
  2. 3.2 Global Ephedrine Revenue by Company (2021-2026)
  3. 3.3 Global Ephedrine Sales Volume by Company (2021-2026)
  4. 3.4 Global Ephedrine Average Price by Company (2021-2026)
  5. 3.5 Global Ephedrine Company Ranking (2024-2026)
  6. 3.6 Global Ephedrine Company Manufacturing Base and Headquarters
  7. 3.7 Global Ephedrine Company Product Type and Application
  8. 3.8 Global Ephedrine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ephedrine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ephedrine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ephedrine Market by Type
  1. 4.1 Ephedrine Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Capsule
  5. 4.2 Global Ephedrine Sales Volume by Type
  6. 4.2.1 Global Ephedrine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ephedrine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ephedrine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ephedrine Sales Value by Type
  10. 4.3.1 Global Ephedrine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ephedrine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ephedrine Sales Value Share by Type (2021-2032)
5 Ephedrine Market by Application
  1. 5.1 Ephedrine Application Introduction
  2. 5.1.1 Recreational use
  3. 5.1.2 Medical use
  4. 5.1.3 Other uses
  5. 5.2 Global Ephedrine Sales Volume by Application
  6. 5.2.1 Global Ephedrine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ephedrine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ephedrine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ephedrine Sales Value by Application
  10. 5.3.1 Global Ephedrine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ephedrine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ephedrine Sales Value Share by Application (2021-2032)
6 Ephedrine Regional Sales and Value Analysis
  1. 6.1 Global Ephedrine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ephedrine Sales by Region (2021-2032)
  3. 6.2.1 Global Ephedrine Sales by Region: 2021-2026
  4. 6.2.2 Global Ephedrine Sales by Region (2027-2032)
  5. 6.3 Global Ephedrine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ephedrine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ephedrine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ephedrine Sales Value by Region (2027-2032)
  9. 6.5 Global Ephedrine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ephedrine Sales Value (2021-2032)
  12. 6.6.2 North America Ephedrine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ephedrine Sales Value (2021-2032)
  15. 6.7.2 Europe Ephedrine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ephedrine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ephedrine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ephedrine Sales Value (2021-2032)
  21. 6.9.2 South America Ephedrine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ephedrine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ephedrine Sales Value Share by Country, 2025 VS 2032
7 Ephedrine Country-level Sales and Value Analysis
  1. 7.1 Global Ephedrine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ephedrine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ephedrine Sales by Country (2021-2032)
  4. 7.3.1 Global Ephedrine Sales by Country (2021-2026)
  5. 7.3.2 Global Ephedrine Sales by Country (2027-2032)
  6. 7.4 Global Ephedrine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ephedrine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ephedrine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ephedrine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ephedrine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ephedrine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ephedrine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ephedrine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ephedrine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ephedrine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ephedrine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ephedrine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ephedrine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ephedrine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ephedrine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ephedrine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ephedrine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ephedrine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ephedrine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ephedrine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ephedrine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ephedrine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ephedrine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ephedrine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ephedrine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ephedrine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ephedrine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ephedrine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ephedrine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ephedrine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ephedrine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ephedrine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ephedrine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ephedrine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ephedrine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ephedrine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ephedrine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ephedrine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ephedrine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ephedrine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ephedrine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ephedrine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ephedrine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ephedrine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ephedrine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ephedrine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ephedrine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ephedrine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ephedrine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ephedrine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ephedrine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ephedrine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ephedrine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ephedrine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ephedrine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ephedrine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ephedrine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ephedrine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ephedrine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ephedrine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ephedrine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ephedrine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ephedrine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ephedrine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ephedrine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ephedrine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ephedrine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ephedrine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ephedrine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ephedrine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ephedrine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ephedrine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ephedrine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ephedrine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ephedrine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ephedrine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ephedrine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ephedrine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ephedrine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ephedrine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ephedrine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ephedrine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ephedrine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ephedrine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ephedrine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ephedrine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ephedrine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Malladi Drugs＆Pharmaceuticals
  2. 8.1.1 Malladi Drugs＆Pharmaceuticals Company Information
  3. 8.1.2 Malladi Drugs＆Pharmaceuticals Business Overview
  4. 8.1.3 Malladi Drugs＆Pharmaceuticals Ephedrine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Malladi Drugs＆Pharmaceuticals Ephedrine Product Portfolio
  6. 8.1.5 Malladi Drugs＆Pharmaceuticals Recent Developments
  7. 8.2 Medarex
  8. 8.2.1 Medarex Company Information
  9. 8.2.2 Medarex Business Overview
  10. 8.2.3 Medarex Ephedrine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medarex Ephedrine Product Portfolio
  12. 8.2.5 Medarex Recent Developments
  13. 8.3 Servier
  14. 8.3.1 Servier Company Information
  15. 8.3.2 Servier Business Overview
  16. 8.3.3 Servier Ephedrine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Servier Ephedrine Product Portfolio
  18. 8.3.5 Servier Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Ephedrine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Ephedrine Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Ephedrine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Ephedrine Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Ephedrine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Ephedrine Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Ephedrine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Roche Ephedrine Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Ephedrine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck Ephedrine Product Portfolio
  48. 8.8.5 Merck Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Ephedrine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Ephedrine Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Ephedrine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Ephedrine Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ephedrine Value Chain Analysis
  2. 9.1.1 Ephedrine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ephedrine Sales Mode & Process
  6. 9.2 Ephedrine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ephedrine Distributors
  9. 9.2.3 Ephedrine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst